Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital

Increasing coronavirus disease 2019 (COVID-19) vaccination rates has been identified by the US Centers of Disease Control and Prevention as critical to ending the COVID-19 pandemic.(1) On May 10, 2021, the Pfizer-BioNTech COVID-19 vaccine (BNT162b2; Pfizer, Inc, New York, New York, and BioNTech SE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Moeller, Karen E., Meeks, Matie, Reynoldson, Jill, Douglass, Michell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Child and Adolescent Psychiatry 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410143/
https://www.ncbi.nlm.nih.gov/pubmed/34481918
http://dx.doi.org/10.1016/j.jaac.2021.08.018
_version_ 1783747101930291200
author Moeller, Karen E.
Meeks, Matie
Reynoldson, Jill
Douglass, Michell
author_facet Moeller, Karen E.
Meeks, Matie
Reynoldson, Jill
Douglass, Michell
author_sort Moeller, Karen E.
collection PubMed
description Increasing coronavirus disease 2019 (COVID-19) vaccination rates has been identified by the US Centers of Disease Control and Prevention as critical to ending the COVID-19 pandemic.(1) On May 10, 2021, the Pfizer-BioNTech COVID-19 vaccine (BNT162b2; Pfizer, Inc, New York, New York, and BioNTech SE, Mainz, Germany) was approved for emergency use authorization by the US Food and Drug Administration for patients 12 years of age or older. Here we report a retrospective study describing the implementation of a COVID-19 vaccination program at our child and adolescent psychiatric hospital. To our knowledge, this is the first report detailing the administration of the COVID-19 vaccination in this setting.
format Online
Article
Text
id pubmed-8410143
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Child and Adolescent Psychiatry
record_format MEDLINE/PubMed
spelling pubmed-84101432021-09-02 Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital Moeller, Karen E. Meeks, Matie Reynoldson, Jill Douglass, Michell J Am Acad Child Adolesc Psychiatry Letter to the Editor Increasing coronavirus disease 2019 (COVID-19) vaccination rates has been identified by the US Centers of Disease Control and Prevention as critical to ending the COVID-19 pandemic.(1) On May 10, 2021, the Pfizer-BioNTech COVID-19 vaccine (BNT162b2; Pfizer, Inc, New York, New York, and BioNTech SE, Mainz, Germany) was approved for emergency use authorization by the US Food and Drug Administration for patients 12 years of age or older. Here we report a retrospective study describing the implementation of a COVID-19 vaccination program at our child and adolescent psychiatric hospital. To our knowledge, this is the first report detailing the administration of the COVID-19 vaccination in this setting. American Academy of Child and Adolescent Psychiatry 2021-11 2021-09-02 /pmc/articles/PMC8410143/ /pubmed/34481918 http://dx.doi.org/10.1016/j.jaac.2021.08.018 Text en ©2021 American Academy of Child and Adolescent Psychiatry. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Moeller, Karen E.
Meeks, Matie
Reynoldson, Jill
Douglass, Michell
Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title_full Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title_fullStr Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title_full_unstemmed Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title_short Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital
title_sort implementation and outcomes of covid-19 vaccinations at a child and adolescent psychiatric hospital
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410143/
https://www.ncbi.nlm.nih.gov/pubmed/34481918
http://dx.doi.org/10.1016/j.jaac.2021.08.018
work_keys_str_mv AT moellerkarene implementationandoutcomesofcovid19vaccinationsatachildandadolescentpsychiatrichospital
AT meeksmatie implementationandoutcomesofcovid19vaccinationsatachildandadolescentpsychiatrichospital
AT reynoldsonjill implementationandoutcomesofcovid19vaccinationsatachildandadolescentpsychiatrichospital
AT douglassmichell implementationandoutcomesofcovid19vaccinationsatachildandadolescentpsychiatrichospital

Ejemplares similares